A comparison of digoxin and medigoxin in treating atrial fibrillation. 1980

E Halley, and T B Counihan

UI MeSH Term Description Entries
D008297 Male Males
D008520 Medigoxin A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE). Metildigoxin,beta-Methyldigoxin,4'''-O-Methyldigoxin,Bemecor,Lanirapid,Lanitop,Medixin,Methyldigoxin,4''' O Methyldigoxin,beta Methyldigoxin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations

Related Publications

E Halley, and T B Counihan
July 1979, British journal of clinical pharmacology,
E Halley, and T B Counihan
July 1978, British journal of clinical pharmacology,
E Halley, and T B Counihan
September 1977, Drug and therapeutics bulletin,
E Halley, and T B Counihan
October 1995, Revista medica de Chile,
E Halley, and T B Counihan
September 1987, Annals of internal medicine,
E Halley, and T B Counihan
February 1987, European heart journal,
E Halley, and T B Counihan
October 2016, Revue medicale suisse,
E Halley, and T B Counihan
January 2012, Advanced pharmaceutical bulletin,
E Halley, and T B Counihan
September 2013, Journal of the Mississippi State Medical Association,
E Halley, and T B Counihan
August 2017, The American journal of emergency medicine,
Copied contents to your clipboard!